pipeline

Diversified Pipeline – Increased Probability of Commercial Success

We have developed a pipeline of novel medicines against our genetically derived targets. As part of maintaining a balanced and broader pipeline, we have both non-partnered and partnered products in development.

Program Discovery Pre-clinical Phase 1 Phase 2 Phase 3 Partners
Oral XEN402
Topical XEN402
Oral XEN403
XEN701